Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0127 |
Glimepiride
Glimperide,HOE-490,格列美脲 |
Potassium Channel | Membrane transporter/Ion channel |
Glimepiride (HOE-490) 是一种中长效的磺酰脲类抗糖尿病化合物,其 ED50=182 μg/k。 | |||
T64332 |
Glimepiride sulfonamide
|
Immunology/Inflammation related | Immunology/Inflammation |
Glimepiride sulfonamide 是一种抗炎活性化合物。 | |||
T35641 |
trans-hydroxy Glimepiride
|
Others | Others |
trans-hydroxy Glimepiride is an active metabolite of the sulfonylurea glimepiride .1It is formed from glimepiride primarily in the liver by the cytochrome P450 (CYP) isoform CYP2C9. 1.Langtry, H.D., and Balfour, J.A.Glimepiride. A review of its use in the management of type 2 diabetes mellitusDrugs55(4)563-584(1998) | |||
T35640 |
trans-carboxy Glimepiride
|
Others | Others |
trans-carboxy Glimepiride is a metabolite of the sulfonylurea glimepiride .1It is formed from glimepiride in a two-step process mediated by the cytochrome P450 (CYP) isoform CYP2C9 and cytosolic enzymes. 1.Noh, K., Kim, E., Jeong, T.C., et al.Simultaneous determination of glimepiride and its metabolites in human plasma by liquid chromatography coupled to a tandem mass spectrometryArch. Pharm. Res.34(12)2073-2078(2011) | |||
T71284 |
Glimepiride urethane
|
Others | Others |
Glimepiride urethane is a third generation sulfonylurea compound, which increases the release of insulin from pancreatic beta cells. In addition, glimepiride increases the activity of intracellular insulin receptors. Glimepiride increases osteoblast proliferation and differentiation, which is thought to be related to its ability to activate the PI3K and Akt pathway. Furthermore, Glimepiride enhances intrinsic peroxisome proliferator-activated receptor γ activity. Glimepiride also increases prote... |